These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23278761)

  • 1. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
    Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
    Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
    Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins.
    Tyynismaa H; Raivio T; Hakkarainen A; Ortega-Alonso A; Lundbom N; Kaprio J; Rissanen A; Suomalainen A; Pietiläinen KH
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E351-5. PubMed ID: 21123446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
    Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans.
    Kralisch S; Tönjes A; Krause K; Richter J; Lossner U; Kovacs P; Ebert T; Blüher M; Stumvoll M; Fasshauer M
    J Endocrinol; 2013 Feb; 216(2):135-43. PubMed ID: 23129782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents.
    Mikolajczak A; Oswiecimska JM; Swietochowska E; Roczniak W; Ziora KT
    Neuro Endocrinol Lett; 2017 Jul; 38(3):173-181. PubMed ID: 28759185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
    Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between pericardial, mediastinal, and intrathoracic fat volumes with the presence and severity of coronary artery disease, metabolic syndrome, and cardiac risk factors.
    Chen O; Sharma A; Ahmad I; Bourji N; Nestoiter K; Hua P; Hua B; Ivanov A; Yossef J; Klem I; Briggs WM; Sacchi TJ; Heitner JF
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):37-46. PubMed ID: 25227267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia.
    Stein S; Stepan H; Kratzsch J; Verlohren M; Verlohren HJ; Drynda K; Lössner U; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2010 Jan; 59(1):33-7. PubMed ID: 19699495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease.
    Konishi M; Sugiyama S; Sugamura K; Nozaki T; Ohba K; Matsubara J; Matsuzawa Y; Sumida H; Nagayoshi Y; Nakaura T; Awai K; Yamashita Y; Jinnouchi H; Matsui K; Kimura K; Umemura S; Ogawa H
    Atherosclerosis; 2010 Apr; 209(2):573-8. PubMed ID: 19892354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity.
    Psyrogiannis AJ; Alexopoulos DK; Kyriazopoulou VE; Vagenakis AG
    Angiology; 1998 Aug; 49(8):607-12. PubMed ID: 9717889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
    Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women.
    De Pergola G; Ciampolillo A; Paolotti S; Trerotoli P; Giorgino R
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):265-9. PubMed ID: 17547687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
    Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
    J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH).
    Urraza-Robledo AI; Giralt M; González-Galarza FF; Villarroya F; Miranda Pérez AA; Ruiz Flores P; Gutiérrez Pérez ME; Domingo P; López-Márquez FC
    PLoS One; 2021; 16(5):e0252144. PubMed ID: 34019585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results.
    Wojcik M; Dolezal-Oltarzewska K; Janus D; Drozdz D; Sztefko K; Starzyk JB
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):537-40. PubMed ID: 22103239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.